歌礼制药-B于2026年11月5日公告，再次在香港联交所场内回购股份。本次回购数量为20万股，占公司已发行股份约0.019%。回购价格最高每股4.925港元、最低4.66港元，合计支付约96.06万港元。
经此次回购后，公司已发行股份数仍为1,052,202,859股，库藏股数量5,784,210股，总股本合计1,057,987,069股。根据公司于2026年6月29日通过的购回授权，公司可回购的股份总数为106,137,084股，截至目前累计已回购5,695,000股，占授权时公司已发行股份总数约0.5366%。
公司确认已遵守《香港联合交易所有限公司证券上市规则》等法律法规的规定。上述公告由公司秘书钟明辉签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.